Long-Term Prognostic Value of Myocardial Fibrosis in Patients With Chagas Cardiomyopathy

被引:61
|
作者
Senra, Tiago [1 ,2 ]
Ianni, Barbara M. [1 ]
Costa, Ana C. P. [1 ]
Mady, Charles [1 ]
Martinelli-Filho, Martino [1 ]
Kalil-Filho, Roberto [1 ]
Rochitte, Carlos E. [1 ]
机构
[1] Univ Sao Paulo, Sch Med, Heart Inst InCor, Ave Dr Eneas de Carvalho Aguiar 44, BR-05403000 Sao Paulo, SP, Brazil
[2] Inst Dante Pazzanese Cardiol, Sao Paulo, Brazil
基金
巴西圣保罗研究基金会;
关键词
cardiac magnetic resonance; Chagas cardiomyopathy; myocardial fibrosis; prognosis; delayed enhancement; MORTALITY; DISEASE; QUANTIFICATION; PREDICTORS; DEATH;
D O I
10.1016/j.jacc.2018.08.2195
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND Myocardial fibrosis (MF) according to cardiac magnetic resonance (CMR) is a frequent finding in Chagas cardiomyopathy and has been associated with risk factors of poor outcome. OBJECTIVES The goal of this study was to determine the prognostic value of MF in predicting combined hard events or all-cause mortality. METHODS Patients with Chagas cardiomyopathy who had a previous CMR evaluation were included, and clinical follow-up was retrospectively obtained. The primary outcome was a combination of all-cause mortality, heart transplantation, antitachycardia pacing or appropriate shock from an implantable cardioverter-defibrillator, and aborted sudden cardiac death; the secondary outcome was all-cause mortality. RESULTS A total of 130 patients were included; mean age was 53.6 +/- 11.5 years, and 53.9% were female. The majority of patients reported no symptoms of heart failure or arrhythmia, but electrocardiographic and echocardiographic abnormalities were common. On CMR, left ventricular dilatation and dysfunction were frequent, and MF was found in 76.1%, with a mean mass of 15.2 +/- 16.5 g. Over a median follow-up of 5.05 years, 58 (44.6%) patients reached the combined endpoint, and 45 (34.6%) patients died. MF was associated with the primary outcome as a continuous variable (adjusted hazard ratio: 1.031; 95% CI: 1.013 to 1.049; p = 0.001) and as a categorical variable (MF >= 12.3 g) (adjusted hazard ratio: 2.107; 95% CI: 1.111 to 3.994; p = 0.022), independently from the Rassi risk score. MF expressed as a continuous variable was also associated with all-cause mortality (adjusted hazard ratio: 1.028; 95% CI: 1.005 to 1.051; p = 0.017) independently from the Rassi risk score. CONCLUSIONS MF is an independent predictor of adverse outcome in Chagas cardiomyopathy. Our data may support the use of CMR in better risk-stratifying this population and possibly guiding therapy. (c) 2018 by the American College of Cardiology Foundation.
引用
收藏
页码:2577 / 2587
页数:11
相关论文
共 50 条
  • [1] Long-Term Prognostic Value of Myocardial Fibrosis in Chagas' Disease
    Senra, Tiago
    Ianni, Barbara
    Mady, Charles
    Martinelli, Martino
    Filho, Roberto Kalil
    Rochitte, Carlos E.
    [J]. CIRCULATION, 2016, 134
  • [2] Long-term prognostic value of an index of myocardial performance in patients with myocardial infarction
    Szymanski, P
    Rezler, J
    Stec, S
    Budaj, A
    [J]. CLINICAL CARDIOLOGY, 2002, 25 (08) : 378 - 383
  • [3] Long-term prognostic value of lowering in free triiodothyronine in patients with hypertrophic cardiomyopathy
    孟祥彬
    [J]. China Medical Abstracts (Internal Medicine), 2018, 35 (02) : 93 - 94
  • [4] Long-term prognostic value of myocardial perfusion stress echocardiography in diabetic patients
    Wejner-Mik, P.
    Lipiec, P.
    Kasprzak, J. D.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183 : 695 - 696
  • [5] Long-term prognostic value of myocardial perfusion stress echocardiography in diabetic patients
    Wejner-Mik, P.
    Lipiec, P.
    Kasprzak, J. D.
    [J]. EUROPEAN HEART JOURNAL, 2011, 32 : 695 - 696
  • [6] Long-Term Prognostic Value of Appropriate Myocardial Perfusion Imaging
    Koh, Angela S.
    Lye, Weng Kit
    Chia, Shaw Yang
    Salunat-Flores, Jennifer
    Sim, Ling L.
    Keng, Felix Y. J.
    Tan, Ru San
    Chua, Terrance S. J.
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2017, 119 (12): : 1957 - 1962
  • [7] Prognostic value of atrial fibrillation in patients with dilated cardiomyopathy:: a long-term study of 12 years
    Hofmann, M
    Goedel-Meinen, L
    Ryba, S
    Schömig, A
    [J]. EUROPEAN HEART JOURNAL, 2000, 21 : 427 - 427
  • [8] Long-term prognostic value of late gadolinium enhancement in a cohort of patients with nonischemic dilated cardiomyopathy
    Rodriguez-Capitan, Jorge
    Manuel Garcia-Pinilla, Jose
    Ruiz-Zamora, Isabel
    Rueda-Calle, Eloy
    Morcillo-Hidalgo, Luis
    Jurado-Canca, Carmen
    Robledo-Carmona, Juan
    Jose Gomez-Doblas, Juan
    de Teresa-Galvan, Eduardo
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2014, 177 (01) : 17 - 19
  • [9] Long-term prognostic value of late gadolinium enhancement in a cohort of patients with nonischemic dilated cardiomyopathy
    Ana Rita Pereira, A. R.
    Almeida, A. R.
    Cruz, I.
    Marques, A.
    Alegria, S.
    Gomes, A. C.
    Sebaiti, D.
    Briosa, A.
    Lopes, L. R.
    Ramalho, M.
    Pereira, H.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 : 526 - 526
  • [10] Long-Term Survival Outcomes after Heart Transplantation in Patients with Chagas Cardiomyopathy
    Nattiv, J.
    Liu, G. S.
    Banankhah, P.
    Genyk, P. A.
    Kingsford, P. A.
    Li, J. P.
    Chand, R. R.
    Vucicevic, D.
    Pandya, K.
    Rahman, J.
    Wolfson, A. M.
    DePasquale, E. C.
    Vaidya, A. S.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2020, 39 (04): : S481 - S482